TRAP1 regulates autophagy in lung cancer cells

TRAP1 regulates autophagy in lung cancer cells INTRODUCTIONTumour Necrosis Factor Receptor‐Associated Protein 1 (TRAP1) is a member of the HSP90 family with predominantly mitochondrial localization, whose cytoprotective role has been widely documented. Several studies suggest that TRAP1 preserves cellular function by protecting mitochondrial function, limiting the effects of oxidative stress either by decreasing reactive oxygen species (ROS)‐mediated oxidation or by attenuating ROS production and through preservation of the mitochondrial membrane potential by limiting mitochondrial permeability transition pore (mPTP) opening through its interaction with HSP90 and cyclophilin D (CypD). Recent studies identify additional cytoprotective roles for TRAP1 in cellular stress responses including the unfolded protein response to ER stress and autophagy. Together, these effects seem to contribute for TRAP1 protective effect against apoptosis. These anti‐apoptotic functions contribute to human oncogenesis. TRAP1 expression is increased in numerous human malignancies. Functionally, inhibition of mitochondrial TRAP1 and related chaperones is cytotoxic to tumour cells, but not normal cells. Anti‐apoptotic functions of TRAP1 confer tumour cells resistance against different chemotherapeutic agents. For these reasons, TRAP1 has been proposed as a potential biomarker and target for anticancer therapies. In this context, mitochondrial‐targeted agents have been developed to selectively inhibit HSP90‐like mitochondrial chaperones inducing cell death and reverting tumour cell multi‐drug‐resistant phenotype.It has http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Clinical Investigation Wiley

Loading next page...
 
/lp/wiley/trap1-regulates-autophagy-in-lung-cancer-cells-ttlwD0jkn7
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
Copyright © 2018 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd
ISSN
0014-2972
eISSN
1365-2362
D.O.I.
10.1111/eci.12900
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONTumour Necrosis Factor Receptor‐Associated Protein 1 (TRAP1) is a member of the HSP90 family with predominantly mitochondrial localization, whose cytoprotective role has been widely documented. Several studies suggest that TRAP1 preserves cellular function by protecting mitochondrial function, limiting the effects of oxidative stress either by decreasing reactive oxygen species (ROS)‐mediated oxidation or by attenuating ROS production and through preservation of the mitochondrial membrane potential by limiting mitochondrial permeability transition pore (mPTP) opening through its interaction with HSP90 and cyclophilin D (CypD). Recent studies identify additional cytoprotective roles for TRAP1 in cellular stress responses including the unfolded protein response to ER stress and autophagy. Together, these effects seem to contribute for TRAP1 protective effect against apoptosis. These anti‐apoptotic functions contribute to human oncogenesis. TRAP1 expression is increased in numerous human malignancies. Functionally, inhibition of mitochondrial TRAP1 and related chaperones is cytotoxic to tumour cells, but not normal cells. Anti‐apoptotic functions of TRAP1 confer tumour cells resistance against different chemotherapeutic agents. For these reasons, TRAP1 has been proposed as a potential biomarker and target for anticancer therapies. In this context, mitochondrial‐targeted agents have been developed to selectively inhibit HSP90‐like mitochondrial chaperones inducing cell death and reverting tumour cell multi‐drug‐resistant phenotype.It has

Journal

European Journal of Clinical InvestigationWiley

Published: Jan 1, 2018

Keywords: ; ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial